The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer Causes and Control

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10552-010-9713-4PMID 21170754PMCID PMC3042514
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is statin use associated with prostate cancer aggressiveness?

  2010cited by this paper
• Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001–2004

  2010cited by this paper
• Association between Statins and Prostate Tumor Inflammatory Infiltrate in Men Undergoing Radical Prostatectomy

  2010cited by this paper
• Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity

  2010cited by this paper
• Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial

  2010cited by this paper
• The association between statin use and the diagnosis of prostate cancer in a population based cohort.

  2010influential reference
• Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial

  2009influential reference
• IS STATIN USE ASSOCIATED WITH PROSTATE CANCER AGGRESSIVENESS

  2009cited by this paper
• PSA and body composition by dual X‐Ray absorptiometry (DXA) in NHANES

  2009cited by this paper
• Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volume.

  2009cited by this paper
• Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

  2009cited by this paper
• Statin use and prostate cancer risk in a large population-based setting

  2008cited by this paper
• Statin use and risk of prostate cancer: results from a population-based epidemiologic study.

  2008cited by this paper
• The influence of statin medications on prostate-specific antigen levels.

  2008cited by this paper
• The association between statins and cancer incidence in a veterans population.

  2008cited by this paper
• Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community‐dwelling men

  2008cited by this paper
• Screening statins for possible carcinogenic risk: up to 9 years of follow‐up of 361 859 recipients

  2008cited by this paper
• Do Statins Affect Androgen Levels in Men? Results from the Boston Area Community Health Survey

  2007cited by this paper
• Statin Use and Risk of Prostate Cancer in the California Men's Health Study Cohort

  2007cited by this paper
• Blood Levels of Long-Chain Polyunsaturated Fatty Acids, Aspirin, and the Risk of Colorectal Cancer

  2007cited by this paper
• WHAT IS THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF PROSTATE CANCER?

  2007cited by this paper
• Atorvastatin treatment for men with lower urinary tract symptoms and benign prostatic enlargement.

  2007cited by this paper
• Cholesterol-Lowering Drugs and Prostate Cancer Risk: A Population-based Case-Control Study

  2007cited by this paper
• Cholesterol-Lowering Drugs and Advanced Prostate Cancer Incidence in a Large U.S. Cohort

  2007cited by this paper
• The association between body size, prostate volume and prostate-specific antigen

  2007cited by this paper
• Statin drugs and risk of advanced prostate cancer.

  2006influential reference
• Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-2002.

  2006influential reference
• Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer.

  2005cited by this paper
• Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms

  2005influential reference
• Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.

  2004cited by this paper
• Association of hypertension with symptoms of benign prostatic hyperplasia.

  2004cited by this paper
• The role of inflammation in the pathogenesis of prostate cancer.

  2004cited by this paper
• Improving overall men's health and potentially reducing the risk of certain cancers via serum markers and risk assessment for coronary heart disease.

  2004cited by this paper
• A big study yields big questions.

  2003cited by this paper
• The influence of finasteride on the development of prostate cancer.

  2003cited by this paper
• Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials.

  1997cited by this paper
• The development of human benign prostatic hyperplasia with age.

  1984cited by this paper

• Statin and other antilipemic use and prostate cancer : Results from the EPICAP study.

  2025cites this paper
• Association Between Statin Exposure and Incidence and Prognosis of Prostate Cancer

  2023cites this paper
• Association of Statin Use with the Risk of Incident Prostate Cancer: A Meta-Analysis and Systematic Review

  2022cites this paper
• Effect of Statins on the Risk of Different Stages of Prostate Cancer: A Meta-Analysis

  2021cites this paper
• Inhibition of Scavenger Receptor Class B Type 1 (SR-B1) Expression and Activity as a Potential Novel Target to Disrupt Cholesterol Availability in Castration-Resistant Prostate Cancer

  2021influential citation
• Prostate cancer incidence and mortality among men using statins and non-statin lipid-lowering medications.

  2019cites this paper
• Statin use linked with a decrease in the conversion from high-grade prostatic intraepithelial neoplasia (HGPIN) to prostate cancer

  2018cites this paper
• The association of statin use with risk of kidney , bladder and prostate cancer : a systematic review and meta-analysis of cohort studies

  2018influential citation
• Preoperative Statin Use Associated With Lower PSA But Similar Prostate Size and Histopathologic Outcomes: Implications for Active Surveillance?

  2017influential citation
• The current evidence on statin use and prostate cancer prevention: are we there yet?

  2017cites this paper
• Biologic and epidemiologic evidence assessing if statins prevent prostate cancer.

  2017cites this paper
• LDL-lowering therapy and the risk of prostate cancer: a meta-analysis of 6 randomized controlled trials and 36 observational studies

  2016cites this paper
• Statin Use in Prostate Cancer: An Update

  2016cites this paper
• Current and Emerging Uses of Statins in Clinical Therapeutics: A Review

  2016cites this paper
• Effect of statins type on incident prostate cancer risk: a meta-analysis and systematic review

  2016cites this paper
• Histopathologic Parameters Accompanying by Incidental Prostate Cancer

  2016cites this paper
• Statin use after radical prostatectomy reduces biochemical recurrence in men with prostate cancer

  2015cites this paper
• Statin use and risk of prostate cancer: Results from the Southern Community Cohort Study

  2015cites this paper
• Use of statins and serum levels of Prostate Specific Antigen

  2015cites this paper
• Effects of 14 frequently used drugs on prostate-specific antigen expression in prostate cancer LNCaP cells

  2014cites this paper
• Simvastatin reduces melanoma progression in a murine model

  2013cites this paper
• Diabetes and prostate cancer screening in black and white men

  2013cites this paper
• Altered cholesterol metabolism in human cancers unraveled by label-free spectroscopic imaging

  2013influential citation
• New Players for Advanced Prostate Cancer and the Rationalisation of Insulin-Sensitising Medication

  2013influential citation
• Healthcare associated infections in children-where are we now ?

  2012cites this paper
• Cholesterol and prostate cancer.

  2012cites this paper
• Statin Use and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies

  2012influential citation
• The effect of demographic and clinical factors on the relationship between BMI and PSA levels

  2011cites this paper
• Differential Effects of Pravastatin and Simvastatin on the Growth of Tumor Cells from Different Organ Sites

  2011cites this paper
• Statyny — jakie były znaczące wydarzenia ubiegłego roku?

  2011cites this paper
• 2059 THE EFFECT OF DEMOGRAPHIC AND CLINICAL FACTORS ON THE RELATIONSHIP BETWEEN BMI AND PSA LEVELS

  2010cites this paper